| Tag | Content |
|---|
EnhancerAtlas ID | HS111-02664 |
Organism | Homo sapiens |
Tissue/cell | KB |
Coordinate | chr19:36192970-36193820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59463 | chr19:36184851-36210443 | Ly3 | | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | GTCAGGCTGG TCTCGAACTC CTGACCTCAG GTGATCTGCC CGCCTTAGCC TCCCAAAGTG 60
CTGGGATTAC AGGCGTGAGC CACCACGTCC GGCCCCTTCC CCCATTTTAG CGGTTTCGCT 120
CCCTATCGGG GCCAGGGACG CCTCAGGCTG TCTCGGTCAG GACCTACAGC TCCGGTTGTT 180
GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC CACCCCCATT CCTCCCCACT 240
CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC GCGCACAACA ACACTCCGCG CAGCGGGAAG 300
GTACCGAACT CGCATCGCAG CCTGAAACTG CTCAACTAAG CTCCCGCCCC GCTGCTCTCT 360
GGTCAATCTA AAGCGAAGAC GAGCCTTAGG GCCAATCAGA AGCGACAGCG GTGGAGTCAT 420
GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC ATTGGCTATG CTTGAGAACG AATCCCAGGC 480
TAAGCCACTT AGAAAGGAGC GGAGCCAGCC AATCAGCGGT GCAACCGCCG CGGGGGCCGG 540
GCCAGAAGCC CCGCAGACAA GCACCTCGGG AGACTGGCGA GGGGCGAGCT CGCAGCTTGT 600
TAGCCCCGAA GCCCTGCCCA GGGGGAAACC CTGCTGGAGG GAGTCTAACC CCCGGGCCAG 660
TTAATGTTGG GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT ATGGTTGGAG GTGGGAGTGC 720
TGACACGTCC GCGCGCAGTT ACTCCTGGCT GAGCATACAG TCGAGGTGGC AGTGGGAATT 780
GGAAGTGCAA GTGTCACGCT GCCAATCACG GGGCAAGGCA CTGCCCCCCT CTTGTGTCTT 840
TCCTGTCCCT 850
|
